424: We may need to reconsider the power of antidepressants | Internal medicine doctor Austin Perlmutter, M.D.
The mindbodygreen Podcast
mindbodygreen
4.5 • 2.1K Ratings
🗓️ 4 August 2022
⏱️ 39 minutes
🧾️ Download transcript
Summary
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Welcome to the MyBuddyGreen podcast. I'm Jason Wackib, founder and co-CEO of MyBuddyGreen and |
| 0:05.6 | your host. Dr. Austin Pearlmutter is an internal medicine doctor who now focuses on helping people |
| 0:13.0 | improve their health through better decisions, neuroscience, and lifestyle interventions. |
| 0:18.8 | He is a New York Times bestselling author of Brainwash and Senior Director of Science and Clinical |
| 0:25.7 | Innovation at Big Old Health. Austin, welcome. Jason, great to see you again. Thanks for having me. |
| 0:33.8 | Great to see you. You know, we're here today to talk about a pretty interesting |
| 0:41.4 | paper to say the least, which came out about a week ago in Nature's Molecular Psychiatry. |
| 0:49.5 | And this paper is getting a ton of attention because essentially what it does is cast |
| 0:54.3 | serious doubt about the role that serotonin, specifically serotonin deficiency, plays in depression, |
| 1:04.2 | which essentially calls into question the prescription of SSRIs for those suffering from depression, |
| 1:13.9 | kind of a bombshell. So I saw this paper quickly. I saw what you were putting on Instagram and |
| 1:21.1 | I thought what you were putting out was was really interesting and smart and thought provoking. |
| 1:27.6 | So I'm going to pause there. What do you think about the implications of this research? |
| 1:34.2 | Well, Jason, I think we need to start with a couple of facts. One is depression is a huge deal |
| 1:40.2 | in the United States and around the world. We're talking hundreds of millions of people right now |
| 1:45.0 | who are suffering from clinical depression. And there are probably a lot of other hundreds of |
| 1:50.0 | millions, if not more, people suffering from subclinical depression, meaning they don't quite |
| 1:54.4 | meet the criteria for that diagnosis. And when we think about how that's going, we realize that |
| 2:02.1 | even with the best therapies, which right now would be something like a SSRI or selective serotonin |
| 2:08.0 | reuptake inhibitor, there's probably a third to even more people who are not really getting |
| 2:13.9 | remission, not really getting a significant benefit. So that's kind of the state of things. And it's |
| 2:19.5 | even worse in countries that don't have great access to care where probably 85% plus of people |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from mindbodygreen, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of mindbodygreen and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.

